Hydrocortison Wagner (Hydrocortisone Acetate)

Hydrocortison Wagner is indicated for the topical management of several inflammatory skin disorders where reduction of redness, swelling, and itching is desired.

• Eczema (atopic dermatitis) and associated pruritus.
• Contact dermatitis caused by irritants or allergens.
• Mild to moderate plaque psoriasis.
• Seborrheic dermatitis affecting scalp or facial areas.
• Other localized inflammatory skin conditions such as discoid lupus erythematosus or lichen planus.
• Acute flare‑ups of chronic dermatitis where rapid symptom control is needed.
• Minor skin irritations after cosmetic procedures or minor burns.

• Hydrocortison Wagner delivers hydrocortisone acetate to the epidermis, where the compound penetrates keratinocytes and binds intracellular glucocorticoid receptors. The receptor‑ligand complex translocates to the nucleus and interacts with glucocorticoid response elements, modulating transcription of anti‑inflammatory genes while suppressing pro‑inflammatory cytokines such as interleukin‑1, interleukin‑6, and tumor necrosis factor‑α. This results in reduced leukocyte migration, edema, and immune activation in the treated skin area.

Topical application of Hydrocortison Wagner may be associated with local skin reactions, most of which are mild and reversible.

Common

• Burning or stinging sensation at the application site, usually lasting a few minutes.
• Mild itching or dryness that may improve with continued use.
• Redness or mild erythema localized to the treated area.
• Peeling or flaking of the treated skin, indicating superficial desquamation.
• Temporary discoloration or hypopigmentation that usually resolves after discontinuation.

Serious

• Skin atrophy or thinning with prolonged use, which may be irreversible if therapy continues.
• Development of striae (stretch marks) on treated areas, especially with occlusive dressings.
• Suppression of local immune response leading to secondary bacterial or fungal infection, requiring medical attention.

When using Hydrocortison Wagner, certain precautions help minimize risks and ensure safe application.

• Apply a thin layer only to affected skin; avoid occlusive dressings unless directed.
• Limit duration of therapy; prolonged use raises risk of skin atrophy and systemic absorption.
• Do not treat broken, infected, or ulcerated skin without medical advice.
• Keep out of reach of children; accidental ingestion may cause systemic corticosteroid effects.
• Discontinue and seek medical help if swelling, rash, severe itching, or other signs of allergic reaction appear.

Hydrocortison Wagner may interact with other topical or systemic agents that affect skin integrity or corticosteroid metabolism.

Avoid

• Concurrent use with other potent topical corticosteroids on the same area, which can increase the risk of skin atrophy.
• Application over skin treated with calcineurin inhibitors (e.g., tacrolimus) without physician guidance, due to additive immunosuppression.

Use with caution

• Use together with systemic corticosteroids; monitor for signs of systemic glucocorticoid excess.
• Co‑application with skin‑drying agents such as benzoyl peroxide or retinoids, which may increase irritation.
• Use in combination with antiviral or antifungal creams; ensure the underlying infection is adequately treated before adding corticosteroid therapy.